---

2016

ルーム内検索
全46件  <<前の20件 1  2  3 次の20件>>
ID
トピック名
閲覧/投稿
最新投稿
作成
308 【臨床研究】CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma. 346 / 0
2016-10-14
KMF CRC
307 【基礎研究】APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment. 314 / 0
2016-10-14
KMF CRC
306 【基礎研究】A transplant immunome" screening platform defines a targetable epitope fingerprint of multiple myeloma." 320 / 0
2016-10-14
KMF CRC
305 【臨床研究】Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients. 364 / 0
2016-10-14
KMF CRC
304 【臨床研究】Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1. 446 / 0
2016-10-14
KMF CRC
303 【レビュー】Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group. 370 / 0
2016-10-14
KMF CRC
302 【基礎研究】MUC1-C drives MYC in multiple myeloma. 308 / 0
2016-10-14
KMF CRC
301 【臨床研究】VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial. 396 / 0
2016-10-14
KMF CRC
300 【臨床研究】Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma. 448 / 0
2016-10-14
KMF CRC
299 【臨床研究】Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma. 302 / 0
2016-10-14
KMF CRC
298 【基礎研究】Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition. 366 / 0
2016-10-14
KMF CRC
297 【基礎研究】Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance. 374 / 0
2016-10-14
KMF CRC
296 【基礎研究】The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice. 357 / 0
2016-10-14
KMF CRC
295 【臨床研究】Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis. 364 / 0
2016-10-14
KMF CRC
294 【基礎研究】Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells. 336 / 0
2016-10-14
KMF CRC
293 【臨床研究】Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma. 315 / 0
2016-10-14
KMF CRC
292 【臨床研究】Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma. 376 / 0
2016-10-14
KMF CRC
291 【基礎研究】Plasma cell myeloma with lymphoplasmacytic morphology and cyclin D1 expression. 334 / 0
2016-10-14
KMF CRC
290 【基礎研究】Pomalidomide reverses γ-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors. 346 / 0
2016-10-14
KMF CRC
289 【基礎研究】Down the repressors! Up the fetal hemoglobin! 309 / 0
2016-10-14
KMF CRC
全46件  <<前の20件 1  2  3 次の20件>>